Melanoma, Secondary cancers, Skin cancer
Open
Phase 3
This trial is looking at a new combination of treatment with brenetafusp and nivolumab. It is comparing this to with nivolumab on its own or with relatlimab.
It is for people with melanoma of the skin:
that can’t be removed with surgery or
that has spread to another part of the body
Please note, you can’t take part if you have melanoma of the eye (uveal melanoma).
Recruitment start: 10 July 2024
Recruitment end: 27 December 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor James Larkin
Immunocore
Last reviewed: 08 Oct 2025
CRUK internal database number: 20043
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
